Collegium Pharmaceutical Stock Price on February 21, 2024
| COLL Stock | USD 30.79 0.83 2.77% |
Below is the normalized historical share price chart for Collegium Pharmaceutical extending back to May 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Collegium Pharmaceutical stands at 30.79, as last reported on the 26th of November, with the highest price reaching 31.15 and the lowest price hitting 30.15 during the day.
If you're considering investing in Collegium Stock, it is important to understand the factors that can impact its price. Collegium Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Collegium Pharmaceutical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Collegium Pharmaceutical's Risk Adjusted Performance of (0.07), mean deviation of 1.88, and Standard Deviation of 2.37 to double-check the risk estimate we provide.
At this time, Collegium Pharmaceutical's Liabilities And Stockholders Equity is quite stable compared to the past year. Capital Stock is expected to rise to about 39 K this year, although the value of Total Stockholder Equity will most likely fall to about 127.6 M. . At this time, Collegium Pharmaceutical's Price Earnings Ratio is quite stable compared to the past year. Price To Operating Cash Flows Ratio is expected to rise to 3.97 this year, although Price Book Value Ratio will most likely fall to 5.18. Collegium Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of May 2015 | 200 Day MA 35.386 | 50 Day MA 35.6868 | Beta 0.949 |
Collegium |
Sharpe Ratio = -0.1111
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | COLL |
Estimated Market Risk
| 2.4 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Collegium Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Collegium Pharmaceutical by adding Collegium Pharmaceutical to a well-diversified portfolio.
Price Book 4.1242 | Enterprise Value Ebitda 4.9627 | Price Sales 1.6124 | Shares Float 29.5 M | Wall Street Target Price 42.25 |
Related Headline
Evolus Headline on 21st of February 2024
Acquisition by Sandra Beaver of 13115 shares of Evolus subje... by Sandra Beaver
Filed transaction by Evolus Inc Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Collegium Pharmaceutical Valuation on February 21, 2024
It is possible to determine the worth of Collegium Pharmaceutical on a given historical date. On February 21, 2024 Collegium was worth 32.12 at the beginning of the trading date compared to the closed value of 31.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Collegium Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Collegium Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Collegium Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Collegium Pharmaceutical's related companies.
| Open | High | Low | Close | Volume | |
| 32.14 | 32.20 | 31.48 | 32.08 | 270,788 | |
02/21/2024 | 32.12 | 32.42 | 31.34 | 31.76 | 386,896 |
| 32.04 | 33.00 | 31.72 | 32.81 | 779,341 |
| Backtest Collegium Pharmaceutical | | | Collegium Pharmaceutical History | | | Collegium Pharmaceutical Valuation | Previous | Next |
Collegium Pharmaceutical Trading Date Momentum on February 21, 2024
| On February 22 2024 Collegium Pharmaceutical was traded for 32.81 at the closing time. The top price for the day was 33.00 and the lowest listed price was 31.72 . The trading volume for the day was 779.3 K. The trading history from February 22, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 3.31% . The overall trading delta against the current closing price is 18.14% . |
Collegium Pharmaceutical Fundamentals Correlations and Trends
By evaluating Collegium Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Collegium Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Collegium financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Collegium Pharmaceutical Stock history
Collegium Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Collegium is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Collegium Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Collegium Pharmaceutical stock prices may prove useful in developing a viable investing in Collegium Pharmaceutical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.8 M | 30.1 M | |
| Net Loss | -28.8 M | -30.2 M |
Collegium Pharmaceutical Stock Technical Analysis
Collegium Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Collegium Pharmaceutical Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Collegium Pharmaceutical cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Collegium Pharmaceutical November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Collegium Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collegium Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Collegium Pharmaceutical stock market strength indicators, traders can identify Collegium Pharmaceutical entry and exit signals to maximize returns
Collegium Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Collegium Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Collegium Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Collegium to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.23) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.49) | Earnings Share 2.34 | Revenue Per Share 18.538 | Quarterly Revenue Growth 0.165 | Return On Assets 0.0968 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.